RBC Capital Cuts Intuitive Surgical (ISRG) Price Target to $550
Key Points
- RBC Capital reiterated an Outperform rating on Intuitive Surgical, Inc. on October 21, 2026, lowering its price target from $575.00 to $550.00.
- RBC Capital's $550 price target implies 29.50% upside from Intuitive Surgical, Inc.'s ($ISRG) current $424.71 share price.
- Intuitive Surgical reported $11.03 billion in trailing-twelve-month revenue alongside earnings of $8.85 per share.
- The stock holds a consensus buy rating across 30 analysts with a mean price target of $478.53.
Get Intuitive Surgical text alerts
We text you when insiders, Congress, analysts or big funds move on $ISRG.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Intuitive Surgical, Inc. alert may contain errors. Disclosures
RBC Capital reiterated its Outperform rating on Intuitive Surgical, Inc. on October 21, 2026, while adjusting its price target on the stock from $575.00 to $550.00. According to research notes released on October 21, 2026, the firm's updated target sits above the broader analyst consensus average.
ISRG
Intuitive Surgical, Inc.
RBC Capital vs. the S&P 500
Hypothetical returns from RBC Capital's disclosed trades, not real profit or advice. How we model this.
Intuitive Surgical, Inc. Stock Down 0.5%
Intuitive Surgical shares recently traded around $424.71 as of October 21, 2026, sitting down about 3.0% from an event-day close of $438.00 on October 20, 2026. The stock trades above its 50-day moving average of $392.76, while resting below its 200-day moving average of $438.97.
$ISRG price target
Intuitive Surgical, Inc. daily closes and this analyst's $550 target. Not advice.
Recent Earnings
Intuitive Surgical reported trailing-twelve-month revenue of $11.03 billion, paired with earnings of $8.85 per share. The medical device maker posted year-over-year revenue growth of 18.5%, supported by a net profit margin of 28.4% and a return on equity of 17.4%. The company carries a trailing price-to-earnings ratio of 48.95 and a forward price-to-earnings ratio of 35.75.
Insider Buying and Selling at Intuitive Surgical, Inc.
Company insiders executed several transactions prior to the October rating update. Officer Mark Preston Brosius sold shares across three dates, including 154 shares on August 21, 2026, 69 shares on September 9, 2026, for $24,671, and 48 shares on September 11, 2026, for $17,141. Additionally, officer Fredrik Widman sold 1,089 shares on September 15, 2026, at an average price of $374.44, generating total proceeds of $407,765.
Analysts Set New Price Targets
Wall Street firms evaluated the stock alongside RBC Capital on October 21, 2026. Evercore ISI Group maintained an In-Line rating with a target of $385.00, lowering it from $400.00. Wells Fargo maintained an Overweight rating, adjusting its target from $487.00 to $486.00. TD Cowen reiterated a Buy rating with an unchanged target of $485.00. Barclays maintained an Overweight rating, raising its target from $485.00 to $500.00. Overall, the stock carries a consensus buy recommendation from 30 analysts with a mean price target of $478.53.
About Intuitive Surgical, Inc.
Based in Sunnyvale, California, Intuitive Surgical designs and manufactures robotic-assisted surgical systems. Its flagship da Vinci surgical system helps doctors perform minimally invasive procedures across various medical specialties. The firm operates globally, supplying hospitals with advanced instruments, accessories, and training programs to support patient care.
Bottom Line
Investors continue to monitor how Intuitive Surgical navigates demand for its robotic platforms against broader healthcare spending trends. Market participants will look toward upcoming earnings reports for further updates on procedure volumes and operating margins.
Related Filing Alerts
Source: RBC Capital's rating change on $ISRG (Oct 21, 2026). Written by software, not financial advice. How we make alerts